Trial Profile
The Study of Early Stage Osteonecrosis of Femoral Head With Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSC)
Status:
Suspended
Phase of Trial:
Phase I/II
Latest Information Update: 17 Apr 2023
Price :
$35
*
At a glance
- Drugs Umbilical cord mesenchymal stem cell therapy Sclnow Biotechnology (Primary)
- Indications Femur head necrosis; Osteonecrosis
- Focus Therapeutic Use
- Sponsors Sclnow Biotechnology
- 11 Apr 2023 Planned End Date changed from 1 Dec 2023 to 1 Dec 2024.
- 11 Apr 2023 Planned primary completion date changed from 1 Jun 2023 to 1 Jun 2024.
- 25 Oct 2022 Planned initiation date changed from 1 Jun 2022 to 1 Dec 2023.